The big business of Australian IVF
A second Australian IVF company wil float on the stock exchange today.
A second Australian IVF company wil float on the stock exchange today. Investment analysts believe that Monash IVF will have a market capitalisation of about A$427 million. Its rival, Virtus Health, is capitalised at $694 million. This means that Australian IVF is at least a $1 billion business. As capital markets expert Paul Docherty explains in this interview in The Conversation, IVF is an attractive investment for institutional investors in Australia because it helps them to diversify their portfolio.
https://www.bioedge.org/images/2008images/TH_busines_of_IVF.jpg
Creative commons
Australia
commercialization
IVF
- How long can you put off seeing the doctor because of lockdowns? - December 3, 2021
- House of Lords debates assisted suicide—again - October 28, 2021
- Spanish government tries to restrict conscientious objection - October 28, 2021
More Stories
Judicial ping-pong leaves Portugal without a right-to-die law
For the second time Portugal’s Constitutional Court has rejected a right-to-die law because its wording is “intolerably vague”. The bill...
Baby steps for ‘death tourism’ in Oregon
A “death tourism” industry is taking off in Oregon, claims the Daily Mail. It says that Dr Nicholas Gideonse, the...
A divorce for the end-of-life dream team
Compassion & Choices and the Alzheimer’s Association have parted ways after a partnership which lasted only a few weeks. On...
‘Your ChatGPT advance directive is ready for signing …’
I couldn’t help thinking of the trash talk at the weigh-in before a professional heavyweight fight when I read the...
Is America’s healthcare system a kleptocapitalist nightmare?
American health care is perishing under the weight of its greed, according to an editorial in JAMA by Donald M....
He did it. Not clear if he’s sorry
The doctor at the heart of a genetic engineering scandal in China has been released from jail and spoke with...